New York – August 12, 2021 – Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced that President and Chief Commercial Officer Fady Boctor is scheduled to present at the following virtual conferences:
Q3 Investor Summit: August 17 – 18, 2021
Mr. Boctor will deliver his corporate presentation on August 17 at 12:30 pm ET.
Management will be available for one-on-one meetings to be held throughout the conference.
Investors can register here: Q3 Investor Summit Investor Registration
SNN Network Summer Virtual Event Investor Conference: August 17 – 19, 2021
Mr. Boctor will deliver his corporate presentation on August 18 at 4:00 pm ET.
Management will be available for one-on-one meetings to be held throughout the conference.
Investors can register here: REGISTER
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health, and substance use disorders.